Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases

go back to reference Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094–1108. https://doi.org/10.1016/S0140-6736(10)60826-4CrossRefPubMed Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094–1108. https://​doi.​org/​10.​1016/​S0140-6736(10)60826-4CrossRefPubMed

go back to reference Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970. https://doi.org/10.1056/NEJMra1505557CrossRefPubMed Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970. https://​doi.​org/​10.​1056/​NEJMra1505557CrossRefPubMed

go back to reference Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574. https://doi.org/10.1056/NEJMra1406182CrossRefPubMed Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574. https://​doi.​org/​10.​1056/​NEJMra1406182CrossRefPubMed

go back to reference Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet Lond Engl 377(9783):2138–2149. https://doi.org/10.1016/S0140-6736(11)60244-4CrossRef Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet Lond Engl 377(9783):2138–2149. https://​doi.​org/​10.​1016/​S0140-6736(11)60244-4CrossRef

go back to reference Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet Lond Engl 369(9563):767–778. https://doi.org/10.1016/S0140-6736(07)60363-8CrossRef Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet Lond Engl 369(9563):767–778. https://​doi.​org/​10.​1016/​S0140-6736(07)60363-8CrossRef

go back to reference Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2016) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977. https://doi.org/10.1136/annrheumdis-2016-210715CrossRef Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2016) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977. https://​doi.​org/​10.​1136/​annrheumdis-2016-210715CrossRef

go back to reference Mian A, Ibrahim F, Scott DL (2019) A systematic review of guidelines for managing rheumatoid arthritis. BMC Rheumatol 3(1):42. https://doi.org/10.1186/s41927-019-0090-7CrossRefPubMedPubMedCentral Mian A, Ibrahim F, Scott DL (2019) A systematic review of guidelines for managing rheumatoid arthritis. BMC Rheumatol 3(1):42. https://​doi.​org/​10.​1186/​s41927-019-0090-7CrossRefPubMedPubMedCentral

go back to reference Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JWJ, Burmester GR, de Wit M, Falzon L, Landewé R (2019) Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis https://doi.org/10.1136/annrheumdis-2019-216656, annrheumdis-2019-216656 Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JWJ, Burmester GR, de Wit M, Falzon L, Landewé R (2019) Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis https://​doi.​org/​10.​1136/​annrheumdis-2019-216656, annrheumdis-2019-216656

go back to reference Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewé R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Cañete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D (2016) European league against rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499–510. https://doi.org/10.1136/annrheumdis-2015-208337CrossRefPubMed Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewé R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Cañete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D (2016) European league against rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499–510. https://​doi.​org/​10.​1136/​annrheumdis-2015-208337CrossRefPubMed

go back to reference Ringold S, Weiss PF, Beukelman T, DeWitt E, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK, American Collge of Rheumatology (2013) 2013 update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis. Arthritis Rheum 65(10):2499–2512. https://doi.org/10.1002/art.38092CrossRefPubMedPubMedCentral Ringold S, Weiss PF, Beukelman T, DeWitt E, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK, American Collge of Rheumatology (2013) 2013 update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis. Arthritis Rheum 65(10):2499–2512. https://​doi.​org/​10.​1002/​art.​38092CrossRefPubMedPubMedCentral

go back to reference van der Heijde D, Ramiro S, Landewé R, Baraliakos X, van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://doi.org/10.1136/annrheumdis-2016-210770CrossRefPubMed van der Heijde D, Ramiro S, Landewé R, Baraliakos X, van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://​doi.​org/​10.​1136/​annrheumdis-2016-210770CrossRefPubMed

go back to reference Maksymowych WP, Gladman D, Rahman P, Boonen A, Bykerk V, Choquette D, Dimond S, Fortin P, Karsh J, Klinkhoff AV, Mosher D, Mulholland K, Olszynski WP, Russell AS, Savage L, Shanner L, Shojania K, Starr M, Thomson G, Zummer M, Inman R, Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada (2007) The Canadian rheumatology association/ Spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project. J Rheumatol 34(11):2273–2284PubMed Maksymowych WP, Gladman D, Rahman P, Boonen A, Bykerk V, Choquette D, Dimond S, Fortin P, Karsh J, Klinkhoff AV, Mosher D, Mulholland K, Olszynski WP, Russell AS, Savage L, Shanner L, Shojania K, Starr M, Thomson G, Zummer M, Inman R, Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada (2007) The Canadian rheumatology association/ Spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project. J Rheumatol 34(11):2273–2284PubMed

go back to reference Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DTY, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of Ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol Hoboken NJ 68(2):282–298. https://doi.org/10.1002/art.39298CrossRef Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DTY, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of Ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol Hoboken NJ 68(2):282–298. https://​doi.​org/​10.​1002/​art.​39298CrossRef

go back to reference Ruiz S (2017) Biosimilars in the EU. Biosimilar Drug Prod Dev 395–411 Ruiz S (2017) Biosimilars in the EU. Biosimilar Drug Prod Dev 395–411

go back to reference European Medicines Agency (2018). Imraldi. https://www.ema.europa.eu/en/medicines/human/EPAR/imraldi. Accessed 24 February 2020 European Medicines Agency (2018). Imraldi. https://​www.​ema.​europa.​eu/​en/​medicines/​human/​EPAR/​imraldi. Accessed 24 February 2020

go back to reference Weinblatt ME, Baranauskaite A, Dokoupilova E, Zielinska A, Jaworski J, Racewicz A, Pileckyte M, Jedrychowicz-Rosiak K, Baek I, Ghil J (2018) Switching from reference adalimumab to SB5 (adalimumab biosimilar) in patients with rheumatoid arthritis: fifty-two-week phase III randomized study results. Arthritis Rheumatol Hoboken NJ 70(6):832–840. https://doi.org/10.1002/art.40444CrossRef Weinblatt ME, Baranauskaite A, Dokoupilova E, Zielinska A, Jaworski J, Racewicz A, Pileckyte M, Jedrychowicz-Rosiak K, Baek I, Ghil J (2018) Switching from reference adalimumab to SB5 (adalimumab biosimilar) in patients with rheumatoid arthritis: fifty-two-week phase III randomized study results. Arthritis Rheumatol Hoboken NJ 70(6):832–840. https://​doi.​org/​10.​1002/​art.​40444CrossRef

go back to reference Weinblatt ME, Baranauskaite A, Niebrzydowski J, Dokoupilova E, Zielinska A, Jaworski J, Racewicz A, Pileckyte M, Jedrychowicz-Rosiak K, Cheong SY, Ghil J, Sokolovic S, Mekic M, Prodanovic N, Gajic B, Karaselimovic-Dzambasovic E, Pojskic B, Toncheva A, Dimitar P, Rodina L, Geneva-Popova M, Staykov I, Stoilov R, Podrazilova L, Mosterova Z, Simkova G, Kopackova J, Stejfova Z, Vencovsky J, Urbanova Z, Janska L, Galatíkova D, Stropuviene S, Sniuoliene I, Sitek-Ziolkowska K, Rell-Bakalarska M, Kolasa R, Daniluk S, Sliwowska B, Bartosik-Twardowska M, Brzezicki J, Konieczny M, Jeka S, Choe J, Bae S, Kang Y, Prystupa L, Vyacheslav Z, Gasanov I, Yatsyshyn R, Rekalov D, Iaremenko O, Stanislavchuk M, Tseluyko V (2018) Phase III randomized study of SB5, an adalimumab biosimilar, versus reference adalimumab in patients with moderate-to-severe rheumatoid arthritis. Arthritis Rheumatol Hoboken NJ 70(1):40–48. https://doi.org/10.1002/art.40336CrossRef Weinblatt ME, Baranauskaite A, Niebrzydowski J, Dokoupilova E, Zielinska A, Jaworski J, Racewicz A, Pileckyte M, Jedrychowicz-Rosiak K, Cheong SY, Ghil J, Sokolovic S, Mekic M, Prodanovic N, Gajic B, Karaselimovic-Dzambasovic E, Pojskic B, Toncheva A, Dimitar P, Rodina L, Geneva-Popova M, Staykov I, Stoilov R, Podrazilova L, Mosterova Z, Simkova G, Kopackova J, Stejfova Z, Vencovsky J, Urbanova Z, Janska L, Galatíkova D, Stropuviene S, Sniuoliene I, Sitek-Ziolkowska K, Rell-Bakalarska M, Kolasa R, Daniluk S, Sliwowska B, Bartosik-Twardowska M, Brzezicki J, Konieczny M, Jeka S, Choe J, Bae S, Kang Y, Prystupa L, Vyacheslav Z, Gasanov I, Yatsyshyn R, Rekalov D, Iaremenko O, Stanislavchuk M, Tseluyko V (2018) Phase III randomized study of SB5, an adalimumab biosimilar, versus reference adalimumab in patients with moderate-to-severe rheumatoid arthritis. Arthritis Rheumatol Hoboken NJ 70(1):40–48. https://​doi.​org/​10.​1002/​art.​40336CrossRef

go back to reference Bae SC, Lee YH (2018) Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Clin Rheumatol 37(5):1199–1205CrossRef Bae SC, Lee YH (2018) Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Clin Rheumatol 37(5):1199–1205CrossRef

go back to reference Di Cesare A, Tronconi G, Fastame TM et al (2020) SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis. Dermatol Ther. https://doi.org/10.1111/dth.13435 Di Cesare A, Tronconi G, Fastame TM et al (2020) SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis. Dermatol Ther. https://​doi.​org/​10.​1111/​dth.​13435

go back to reference Wolfe F, Michaud K, Strand V (2005) Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol 32(4):583–589PubMed Wolfe F, Michaud K, Strand V (2005) Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol 32(4):583–589PubMed

go back to reference Anonymous (2019). A Real-World study of Imraldi ® use (PROPER). https://clinicaltrials.gov/ct2/show/NCT04089514. Accessed 05 May 2020 Anonymous (2019). A Real-World study of Imraldi ® use (PROPER). https://​clinicaltrials.​gov/​ct2/​show/​NCT04089514. Accessed 05 May 2020